Databases: Scientists' and Organizations' Links to Industry
Return to CSPI U.S.
Non-Profit Organizations Receiving Corporate Funding 
Index of Non-Profit Organizations Receiving Corporate Funding


” The Slone Epidemiology Center is a public health research organization which focuses on studying the possible health effects of medications and a wide variety of other factors in adults and children.” (; accessed 5/26/05)

The Slone Epidemiology Center has received support from the following companies: Astra, Aventis, Bayer AG, Bristol-Myers, Celgene, Ciba-Geigy, Glaxo Wellcome, Hoeschst AG, Hoffman-La Roche, Lichtwer, McNeil Consumer Products, Merck Research Laboratories, Merrell Dow, Novartis, Pfizer, Procter and Gamble, Rhone-Poulenc, SmithKline Beecham, Sterling, Warner-Lambert, and Whitehall. (Am J Epidemiol. 2003;158:609-16.)

Case-control study on the association of upper GI bleeding and nonsteroidal anti-inflammatory drugs in Japan, sponsored by Pfizer. (June 2002-2005)

Evaluation of the thalidomide fetal exposure prevention program/thalidomide survey funded by Celgene Corp. (October, 1998 – present)

Pregnancy health interview study/birth defects study supported in part by Hoffman LaRoche and other pharmaceutical companies. (1976 – current)

Thai studies of aplastic anemia and agranulocytosis supported in part by Hoechst AG. (January 1989 – February 2004)

Survey of Isotretinoin use in women funded by Barr Laboratories, Bertek Pharmaceuticals, Ranbaxy Pharmaceuticals (December, 2002 to present)

Post-marketing surveillance of drugs used to treat irritable bowel syndrome using a pharmacy-based cohort funded by GlaxoSmithKline. (February 2002 - July 2002)

Study of Accutane in women supported by Hoffmann-La Roche, Inc. (1989-2003)

Multicenter study of gastroschisis and small intestinal defects (SIA) funded by Warner Lambert Co.; Procter and Gamble Co.; Marion Merrell Dow, Inc. (August 1994 - November 1998)

Study of serious infections in children funded by McNeil Consumer Products Co.; Whitehall-Robins Healthcare (April 1996 – December 1998).

Study of severe anaphylaxsis supported by Hoechst; Ciba-Geigy. (February 1992 - June 1997)

(; accessed 5/26/05)

The Collaborative was established in 1966 and conducts “studies in the field of pharmaco-epidemiology using large automated patient databases.” ( accessed 10/23/01)

Supported in part by grants from Astra AB, Bayer AG, Berlex Laboratories, Boots Healthcare International, Glaxo Wellcome, Hoffman-La Roche, RW Johnson Pharmaceutical Research Institute, McNeil Consumer Products Company, and Novartis Pharmaceuticals. (J. Clin. Pharmacol. 2000;50:46)


Corporate sponsors for research:

  • Celgene Corporation donated $336,000 for “Evaluation of Thalidomide Fetal Exposure Prevention Program”
  • Ranbaxy Pharmaceuticals gave $697,256 to continue support of the multi-year project “Survey of Isotreninoin use in women”
  • McNeill Laboratories donated $80,000 for research awards
  • Merck has donated $75,000 to a medical education fund established in the name of the company
  • Auxilium Pharmaceuticals, Inc. has given $35,000 for a “Sexual Medicine Fellowship”

(; accessed 5/6/05)


The institute sponsors “…studies which look at the effects on health of moderate alcohol consumption, particularly wine.” In 2005 the Institute on Lifestyle and Health, directed by Curtis Ellison, M.D., Professor of Medicine and Chief, Section of Preventive Medicine, has received a $50,000 grant from the Brown-Forman Corporation, a producer of wine and spirit-brands, and $25,000 from the Wine Group, Inc. (; accessed 5/6/05) The institute receives roughly 10% of its funding from the alcoholic beverage industry. (Mortin, Molly. “To your health- Moderating the facts and fears about prescribing wine,” The Seattle Times, 10/11/98, p.6; Kno, Richard A. “Wine labels' approval stirs spirited debate,” The Boston Globe, 2/6/99, p.A3; Burling, Stacey. “Doctors loath to laud alcohol,” The Denver Post, 1/24/00, p.E3)

[Integrity in Science] [CSPI U.S.] Back to Top